Posted Aug. 29, 2012 at 6:42 a.m.

Premium Lock RTP-based Metabolon sues rival biomarker firm

Published: 2012-08-29 06:42:00
Updated: 2012-08-29 06:42:00

Metabolon Metabolon

Stemina Biomarker Discovery Inc. is accused of infringing two patents that cover methods of drug discovery, disease treatment and diagnosis using the study of the chemical processes of metabolites....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2017 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Latest for Insiders